{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Wills Eye Hospital Continuing Medical Education
  • Sign In
  • LIVE COURSES
  • ON DEMAND COURSES
  • REGULARLY SCHEDULED SERIES
  • NEO (HR)
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Sign in with your Company ID User Name & Password
Sign in with your Email and Password
Enter your email and password to login:

*
*
Login

New to Wills Eye Hospital CME? Create an Account:

Create New Account
Forgot Your Password?
NOTE: Your old login from the previous Knowledge Portal will no longer work in this new system. Your log-in is the email address in your new Knowledge Portal account and the password you set for this account.

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • BA
  • BHSA
  • BS
  • CNA
  • CO
  • COMT
  • CPO
  • CPOA
  • CPOT
  • CRA
  • DO
  • DVM
  • LPN
  • MBBS
  • MBChB
  • MD
  • MD, FACS
  • MD, MBA
  • MD, MPH
  • MD, MS, MBA, MPH
  • MD, PhD
  • MPH
  • MS
  • MSE
  • MSN
  • MSN, PPCNP-BC
  • OD
  • Other
  • PhD
  • Physician Assistant
  • PPCNP-BC
  • RN
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

ACRC/Macula 2026


ACRC/Macula 2026 Banner

  • Overview
  • Register
  • Disclosures
  • Schedule
Add to Calendar ACRC/Macula 2026 1/8/2026 12:00:00 PM 1/10/2026 5:20:00 PM America/New_York For More Details: https://willseye.cloud-cme.com/course/courseoverview?EID=948 Description: Join Us for the 50th Annual Atlantic Coast Retina Club (ACRC) & Macula 2026We are pleased to announce the50th Annual Atlantic Coast Retina Club (ACRC)andMacula 2026, taking placeJanuary 8–10, 2026, in historic Philadelphia, Pennsylvania. This milestone event will commence at Wills Eye Hospital on January 8, followed by two full days of programming at The Union League of Philadelphia on January 9–1... The Union League of Philadelphia false MM/DD/YYYY


Date & Location
Thursday, January 8, 2026, 12:00 PM - Saturday, January 10, 2026, 5:20 PM, The Union League of Philadelphia, Philadelphia, PA

Target Audience
Specialties - Retina and Vitreous
Professions - Physician, Researcher, Student

Credits
AMA PRA Category 1 Credits™ (17.25 hours), Non-Physician Attendance (17.25 hours)

Overview

Join Us for the 50th Annual Atlantic Coast Retina Club (ACRC) & Macula 2026

We are pleased to announce the 50th Annual Atlantic Coast Retina Club (ACRC) and Macula 2026, taking place January 8–10, 2026, in historic Philadelphia, Pennsylvania. This milestone event will commence at Wills Eye Hospital on January 8, followed by two full days of programming at The Union League of Philadelphia on January 9–10.

The conference is expected to bring together 300–350 retina specialists. Attendees will engage with an elite faculty of renowned national and international experts who will share cutting-edge insights on the diagnosis, management, and treatment of retinal diseases.

ACRC, January 8-9, 2026, will include mystery case presentations presented by residents, fellows, and faculty in rapid succession with stimulating discussions to follow traditions established in the 1970s by giants of retina including Lawrence Yannuzzi and Jerry Shields.

Macula 2026, January 10, 2026, will feature world-renowned invited speakers who will present the latest innovations in imaging, medical retina, uveitis, tumors, retinal dystrophies, as well as pharmacologic and surgical therapies.

This landmark 50th anniversary event will provide a rich forum for education, collaboration, and innovation in the ever-evolving field of retina.

We look forward to welcoming you to Philadelphia for this exceptional academic experience!


Accreditation
Wills Eye Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


AMA PRA Statement
Wills Eye Hospital designates this for a maximum of 17.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Keywords: LIVEACCMERetina and VitreousCME

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
David H Abramson, MD
MSKCC
Faculty
Nothing to disclose
Thomas A. Albini, MD
BASCOM PLAMER EYE INSTITUTE
Faculty
Tomas S Aleman, MD
Scheie Eye Institute, University of Pennsylvania
Faculty
Royalties or Patent Beneficiary-University of Pennsylvania|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Foundation Fighting Blindness|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Choroideremia Research Foundation|Membership on Advisory Committees or Review Panels, Board Membership, etc.-RDH12 Fund|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Opus Genetics, Inc|Grant or research support-Genentech|Grant or research support-Opus Genetics, Inc.|Grant or research support-Atsena Therapeutics|Grant or research support-Editas Medicine, Inc
Ferhina Ali, MD, MPH
Faculty
J. Fernando Arevalo, MD, PhD
Johns Hopkins' Wilmer Eye Institute
Faculty
Consulting Fee-Genentech|Grant or research support-Topcon Medical Systems Inc|Consulting Fee-EyePoint Pharmaceuticals|Consulting Fee-Astellas Pharma|Consulting Fee-Alimera Sciences (Relationship has ended)|Consulting Fee-Apellis Pharmaceuticals|Consulting Fee-Belite Bio, Inc
caroline baumal, MD
Retina Specialists of Boston and Wellesley
Faculty
Employment-Apellis Pharmaceuticals
William Benson, MD
Wills Eye Patriots
Faculty
Private Corp Stock-Johnson & Johnson
Audina M. Berrocal, MD
Bascom Palmer Eye Institute
Faculty
Maria Berrocal, MD
Faculty
Durga Borkar, MD
Faculty
David S Boyer, MD
Retina vitreous associates
Faculty
Consulting Fee-Acucela (Relationship has ended)|Consulting Fee-Aderum Biotechnologies, Inc.|Consulting Fee-Aerpio (Relationship has ended)|Consulting Fee-Alexion Pharmaceuticals|Consulting Fee-Allergan|Consulting Fee-Amgen|Consulting Fee-Apellis Pharmaceuticals|Consulting Fee-Astellas Pharma|Consulting Fee-Aura Biosciences|Consulting Fee-Bausch + Lomb|Consulting Fee-Bayer (Relationship has ended)|Consulting Fee-Boehringer Ingelheim|Consulting Fee-Chengdu Kanghong Pharmaceutical|Consulting Fee-Clearside Biomedical|Consulting Fee-EyePoint Pharmaceuticals|Consulting Fee-Genentech|Consulting Fee-Glaukos Corporation|Consulting Fee-Johnson & Johnson (Relationship has ended)|Consulting Fee-Kala Pharmaceuticals|Consulting Fee-Kodiak Sciences (Relationship has ended)|Consulting Fee-Neurotech|Consulting Fee-Notal Vision (Relationship has ended)|Consulting Fee-Novartis|Consulting Fee-Ocugen|Consulting Fee-Ocular Therapeutix|Consulting Fee-Ora, Inc.|Consulting Fee-Regeneron|Consulting Fee-REGENXBIO, Inc.|Consulting Fee-Sanofi|Consulting Fee-Santen Pharmaceuticals|Consulting Fee-Roche|Consulting Fee-Sun Pharmaceutical Industries|Consulting Fee-Unity Biotechnology|Consulting Fee-LumiThera
Neil M. M. Bressler, MD
Johns Hopkins University School of Medicine
Faculty
Susan B. Bressler, MD
Johns Hopkins University School of Medicine
Faculty
Grant or research support-Regeneron|Grant or research support (Relationship has ended)|Consulting Fee-Boehringer Ingelheim|Grant or research support-Biocon|Grant or research support-Genentech (Relationship has ended)|Grant or research support-Mylan (Relationship has ended)|Consulting Fee-Amgen (Relationship has ended)
Peter Campochiaro, MD
Faculty
Advisor-Boehringer Ingelheim (Relationship has ended)|Consulting Fee-Bausch + Lomb (Relationship has ended)|Grant or research support-Celanese (Relationship has ended)|Consulting Fee-Clearside Biomedical (Relationship has ended)|Consulting Fee-Cove|Grant or research support-Cove|Stocks or stock options, excluding diversified mutual funds-Cove|Advisor-ExgenesisBio (Relationship has ended)|Consulting Fee-Exonate|Advisor-Genentech|Grant or research support-Genentech|Grant or research support-Ocular Therapeutix (Relationship has ended)|Advisor-Merck|Advisor-Perfuse|Grant or research support-REGENXBIO, Inc.
R.V. Paul Chan, MD, MSc, MBA
Illinois Eye and Ear Infirmary, University of Illinois at Chicago
Faculty
Jay Chhablani, MD
University of Pittsburgh Medical Center
Faculty
Consulting Fee-Bausch + Lomb|Consulting Fee-EyePoint Pharmaceuticals|Consulting Fee-Astellas Pharma|Consulting Fee-Allergan|Consulting Fee-Apellis Pharmaceuticals
Faculty Photos
Allen Chiang, MD
Wills Eye Hospital
Faculty
Grant or research support-Genentech|Grant or research support-Apellis Pharmaceuticals
Donald J. D'Amico, MD
Weill Cornell Medical College/New York-Presbyterian Hospital
Faculty
Faculty Photos
Jordan Deaner, MD
Mid Atlantic Retina, Wills Eye Hospital
Faculty
Consulting Fee-EyePoint Pharmaceuticals (Relationship has ended)|Consulting Fee-ANI (Relationship has ended)|Speakers Bureau-ANI|Consulting Fee-Genentech (Relationship has ended)|Consulting Fee-Bausch + Lomb (Relationship has ended)|Speakers Bureau-Bausch + Lomb|Consulting Fee-Regeneron (Relationship has ended)
Jay S Duker, MD
EyePoint
Faculty
Executive-EyePoint Pharmaceuticals
Faculty Photos
James P. Dunn, MD
Retina Division/Wills Eye Hospital
Faculty
Nothing to disclose
Justis P Ehlers, MD
Cleveland Clinic
Faculty
Dean Eliott, MD
Massachusetts Eye & Ear
Faculty
Philip J. Ferrone, MD
VRCNY
Faculty
Employment-Apellis Pharmaceuticals (Relationship has ended)|Consulting Fee-EyePoint Pharmaceuticals|Grant or research support-Genentech|Consulting Fee-Allergan (Relationship has ended)|Grant or research support-Apellis Pharmaceuticals|Grant or research support-Regeneron|Consulting Fee-Regeneron|Consulting Fee-Alcon|Consulting Fee-Neurotech (Relationship has ended)|Consulting Fee-Zeiss
Jasmine Francis, MD, FACS
Memorial Sloan Kettering Cancer Center
Faculty
Nothing to disclose
K. Bailey Freund, MD
Vitreous Retina Macula Consultants of New York
Faculty
Consulting Fee-Regeneron|Consulting Fee-Apellis Pharmaceuticals (Relationship has ended)|Consulting Fee-EyePoint Pharmaceuticals (Relationship has ended)
Faculty Photos
Sunir J. Garg, MD
MidAtlantic Retina, The Retina Service of Wills Eye Hospital
Faculty
Consulting Fee-Bausch + Lomb|Consulting Fee-Johnson & Johnson (Relationship has ended)|Consulting Fee-Allergan (Relationship has ended)|Consulting Fee-Boehringer Ingelheim|Consulting Fee-Apellis Pharmaceuticals|Consulting Fee-Merck|Consulting Fee-Regeneron|Consulting Fee-Coherus Biosciences (Relationship has ended)|Grant or research support-Allergan (Relationship has ended)|Grant or research support-Boehringer Ingelheim|Grant or research support-Genentech|Grant or research support-Regeneron|Grant or research support-Apellis Pharmaceuticals|Grant or research support-NGM Bio (Relationship has ended)|Grant or research support-Kodiak Sciences (Relationship has ended)|Grant or research support-Alcon|Consulting Fee-Zeiss|Consulting Fee-Merck
James Handa, MD
Wilmer Eye Institute, Johns Hopkins University
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Character Biosciences|Paid consultant-FerRx|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Cirrus Therapeutics
Faculty Photos
Jason Hsu, MD
Wills Eye Physicians-Mid Atlantic Retina
Faculty
Consulting Fee-Astellas (Relationship has ended)|Consulting Fee-Gyroscope Therapeutics (Relationship has ended)|Grant or research support-Genentech|Grant or research support-Astellas Pharma|Grant or research support-Stealth Biotherapeutics|Consulting Fee-Nextech|Grant or research support-Regeneron|Grant or research support-Boehringer Ingelheim|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Neurotech
Douglas Jabs, MD, MBA
Faculty
Nothing to disclose
Glenn Jaffe, MD
Faculty
Talia Kaden, MD
MEETH, Northwell Health
Faculty
Advisor-Genentech|Advisor-Abbvie|Advisor-Alimera Sciences|Advisor-Alcon|Advisor-Apellis Pharmaceuticals
Faculty Photos
Richard S. Kaiser, MD
Mid Atlantic Retina
Faculty
Nothing to disclose
Benjamin J. Kim, MD
Scheie Eye Institute of UPenn
Faculty
Paid consultant-Asclepix Therapeutics (Relationship has ended)|Paid consultant-Lexitas (Relationship has ended)|Paid consultant-Genentech
Ivana K. Kim, MD
Massachusetts Eye and Ear
Faculty
Consulting Fee-Kodiak Sciences
Faculty Photos
Michael Klufas, MD
Mid Atlantic Retina/Wills Eye
Faculty
Consulting Fee-REGENXBIO, Inc.|Consulting Fee-Genentech|Consulting Fee-Regeneron|Honoraria-Coherus (Relationship has ended)|Honoraria-Biogen (Relationship has ended)|Consulting Fee-Abbvie|Grant or research support-Bausch + Lomb|Consulting Fee-Zeiss|Consulting Fee-Alimera Sciences|Stocks or stock options, excluding diversified mutual funds-Horizon Surgical Systems|Consulting Fee-4DMT|Consulting Fee-Bayer
Faculty Photos
Ajay E. Kuriyan, MD
Mid Atlantic Retina/Wills Eye Hospital
Faculty
Stocks or stock options, excluding diversified mutual funds-Recens medical|Grant or research support-4DMT|Speakers Bureau-Genentech|Speakers Bureau-Astellas Pharma|Consulting Fee-Alimera Sciences|Grant or research support-Alcon|Grant or research support-Aderum Biotechnologies, Inc.|Consulting Fee-Allergan|Consulting Fee-Bausch + Lomb|Consulting Fee-Spark Therapeutics|Consulting Fee-EyePoint Pharmaceuticals|Grant or research support-EyePoint Pharmaceuticals|Consulting Fee-Genentech|Grant or research support-Genentech|Consulting Fee-LifeNet Health|Consulting Fee-Novartis|Consulting Fee-Optos, Inc.|Grant or research support-Annexon
Faculty Photos
Sara E. Lally, MD
Shields and Shields
Faculty
Nothing to disclose
Faculty Photos
Sonia Mehta, MD
Wills Eye Hospital
Faculty
Phoebe Mellen, MD
Tufts Medical Center
Faculty
John Miller, MD

Faculty
Yasha S. Modi, MD
New York University
Faculty
Consulting Fee-Alcon|Consulting Fee-Genentech|Consulting Fee-Regeneron|Consulting Fee-Zeiss|Consulting Fee-Topcon|Consulting Fee-4DMT|Consulting Fee-Bausch + Lomb|Consulting Fee-Abbvie|Consulting Fee-Science Corporation|Consulting Fee-EyePoint Pharmaceuticals|Consulting Fee-Neurotech
Faculty Photos
Jose Pulido, MD, MS, MPH, MBA
Wills Eye
Faculty
Nothing to disclose
Ehsan Rahimy, MD
Palo Alto Medical Foundation
Faculty
Richard B. Rosen, MD, ScD(hon),FACS, FASRS, FARVO
New York Eye and Ear Infirmary of Mount Sinai
Faculty
Drew Scoles, MD, PhD
CHOP
Faculty
Consulting Fee-Neolight (Relationship has ended)
Adrienne W. Scott, MD
Johns Hopkins
Faculty
Johanna Seddon , MD
UMass Chan Medical School
Faculty
Consulting Fee-Thea Laboratoires|Public Corp Stock-Apellis Pharmaceuticals|Public Corp Stock-Disc Medicine
Rishi Singh, MD
Faculty
Consulting Fee-Apellis Pharmaceuticals|Consulting Fee-Astellas Pharma|Consulting Fee-Alcon|Consulting Fee-EyePoint Pharmaceuticals|Grant or research support-Janssen|Stocks or stock options, excluding diversified mutual funds-Olin |Stocks or stock options, excluding diversified mutual funds-Aviceda|Consulting Fee-Bausch + Lomb|Consulting Fee-Aderum Biotechnologies, Inc.|Consulting Fee-Genentech|Consulting Fee-Regeneron|Consulting Fee-Topcon
Faculty Photos
Meera Sivalingam, MD
Wills Eye Hospital
Faculty
Sunil Srivastava, MD
Faculty
Matt Starr, MD
Mayo Clinic
Faculty
Advisor-Allergan (Relationship has ended)|Advisor-REGENXBIO, Inc.|Advisor-Alimera Sciences|Advisor-Genentech|Consulting Fee-Gyroscope Therapeutics|Advisor-EyePoint Pharmaceuticals|Advisor-Longbridge Medical|Advisor-Evolve Medical
Katherine Talcott, MD
Cole Eye Institute
Faculty
Consulting Fee-Genentech|Consulting Fee-Ocular Therapeutix|Advisor-Harrow|Consulting Fee-4DMT|Speakers Bureau-Genentech|Consulting Fee-Alimera Sciences|Consulting Fee-Abbvie|Consulting Fee-Apellis Pharmaceuticals|Consulting Fee-Bausch + Lomb|Consulting Fee-EyePoint Pharmaceuticals|Consulting Fee-Outlook|Speakers Bureau-Astellas Pharma|Consulting Fee-Regeneron|Consulting Fee-Zeiss|Speakers Bureau-Zeiss|Other: Research-Zeiss
John T. Thompson, MD
Retina Specialists
Faculty
Grant or research support-Genentech|Grant or research support-Alexion Pharmaceuticals|Grant or research support-Johnson & Johnson|Grant or research support-Ocular Therapeutix
Stephen H. Tsang, MD
Columbia University
Faculty
Brian L. VanderBeek, MD, MPH, MSCE
University of Pennsylvania
Faculty
Demetrios Vavvas, MD
Mass Eye and Ear Harvard Medical School
Faculty
Demetrios G Vavvas, MD, PhD
Mass Eye and Ear
Faculty
Nothing to disclose
Andre J. Witkin, MD
Tufts Medical Center
Faculty
Grant or research support-Apellis Pharmaceuticals|Grant or research support-Genentech
Lawrence A. Yannuzzi, MD
The Macula Foundation, Inc.
Faculty
Nothing to disclose
Nicholas Yannuzzi, MD
Bascom Palmer Eye Institute
Faculty
Yi Zhang, MD, PhD
Faculty
Alexander J. Brucker, MD
Scheie Eye Institute, University of Pennsylvania
Faculty, Planner
Nothing to disclose
Faculty Photos
Julia A. Haller, MD
Wills Eye
Faculty, Planner
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol Myers Squibb|Stocks or stock options, excluding diversified mutual funds-Bristol Myers Squibb|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Opthea|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Outlook Therapeutics|Stocks or stock options, excluding diversified mutual funds-Outlook Therapeutics|Stocks or stock options, excluding diversified mutual funds-Opthea|Consulting Fee-Regeneron|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Aura Biosciences (Relationship has ended)|Consulting Fee-Aura Biosciences (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bionic Sight LLC|Consulting Fee-Bionic Sight LLC|Consulting Fee-Seeing Medicine (Relationship has ended)
Faculty Photos
Allen Ho, MD
Mid Atlantic Retina
Faculty, Planner
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Alcon|Consulting Fee-Aerie Pharmaceuticals|Grant or research support-Aerie Pharmaceuticals|Consulting Fee-Aldeyra|Grant or research support-Aldeyra|Consulting Fee-Astellas Pharma|Consulting Fee-Atsena|Grant or research support-Atsena|Consulting Fee-Chengdu Kanghong Pharmaceutical|Grant or research support-Chengdu Kanghong Pharmaceutical|Consulting Fee-Clearside Biomedical|Consulting Fee-Annexon|Grant or research support-Annexon|Grant or research support-Astellas Pharma|Other: Equity-Covalent Medical, LLC|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Allergan|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Apellis Pharmaceuticals|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genentech|Independent Contractor (included contracted research)-Kodiak Sciences (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Notal Vision|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Regeneron|Membership on Advisory Committees or Review Panels, Board Membership, etc.-REGENXBIO, Inc.|Grant or research support-4DMT|Consulting Fee-Aavantgarde Bio|Consulting Fee-AcuSurgical|Consulting Fee-Adverum|Grant or research support-Adverum|Consulting Fee-Dompé |Consulting Fee-Emmecell|Consulting Fee-EyePoint Pharmaceuticals|Grant or research support-EyePoint Pharmaceuticals|Consulting Fee-Eyevensys|Consulting Fee-Janssen|Grant or research support-Janssen|Consulting Fee-Kiora|Grant or research support-Kiora|Consulting Fee-Lineage|Grant or research support-Lineage|Consulting Fee-Lumithera|Grant or research support-Lumithera|Consulting Fee-Nanoscope|Grant or research support-Nanoscope|Grant or research support-National Eye Institute|Consulting Fee-Notal Vision|Grant or research support-Notal Vision|Consulting Fee-Ocular Therapeutix|Consulting Fee-ONL|Other: Equity-ONL|Consulting Fee-Oxular|Grant or research support-ProQR|Consulting Fee-Stealth|Consulting Fee-Vanotech|Advisor-Ikarovec
Faculty Photos
Carl D. Regillo, MD
Wills Eye-MAR
Faculty, Planner
Consulting Fee-Allergan|Consulting Fee-Apellis Pharmaceuticals|Consulting Fee-EyePoint Pharmaceuticals|Consulting Fee-Genentech|Consulting Fee-Novartis|Consulting Fee-Ocugen|Consulting Fee-REGENXBIO, Inc.|Consulting Fee-Regeneron|Consulting Fee-Astellas Pharma|Consulting Fee-Ocular Therapeutix|Consulting Fee-Zeiss (Relationship has ended)|Consulting Fee-Aderum Biotechnologies, Inc.|Consulting Fee-Alcon|Consulting Fee-Bausch + Lomb|Consulting Fee-Boehringer Ingelheim
Faculty Photos
Carol L. Shields, MD
Shields and Shields MD PC
Faculty, Planner
Advisor-Aura Biosciences|Advisor-Ideaya Biosciences|Advisor-Immunocore|Advisor-iOnctura
Faculty Photos
Arunan Sivalingam, MD
Retina Service, Wills Eye
Faculty, Planner
Nothing to disclose
Faculty Photos
Yoshihiro Yonekawa, MD
Wills Eye Hospital / Mid Atlantic Retina
Faculty, Planner
Consulting Fee-Alcon (Relationship has ended)|Consulting Fee-Bausch + Lomb (Relationship has ended)|Consulting Fee-Apellis Pharmaceuticals (Relationship has ended)|Consulting Fee-Genentech|Grant or research support-Genentech|Grant or research support-Regeneron|Grant or research support-Ocugen|Grant or research support-Kyowa Kirin|Grant or research support-Eyebiotech

Thursday, January 8, 2026
Friday, January 9, 2026
Saturday, January 10, 2026
Breakfast
7:00AM - 7:30AM

Exhibits
7:00AM - 3:30PM

Registration
7:00AM - 5:00PM

Welcome Remarks
7:30AM - 7:40AM
Carl D. Regillo, MD
Yoshihiro Yonekawa, MD

Latest Findings from Pegcetacoplan Trials for Geographic Atrophy in AMD
7:40AM - 7:46AM
Ferhina Ali, MD, MPH (Faculty)

Session 1 – Dry AMD
7:40AM - 8:31AM
Alexander J. Brucker, MD (Moderator)
Jason Hsu, MD (Moderator)

Discussion
7:46AM - 7:49AM

Imaging Biomarkers for Dry Age-Related Macular Degeneration
7:49AM - 7:55AM
Justis P Ehlers, MD (Faculty)

Discussion
7:55AM - 7:58AM

Can Visual Acuity be Estimated Using Multimodal Imaging in Geographic Atrophy?
7:58AM - 8:04AM
caroline baumal, MD (Faculty)

Discussion
8:04AM - 8:07AM

Innovative Imaging: Unveiling New Insights into Age-Related Macular Degeneration
8:07AM - 8:13AM
K. Bailey Freund, MD (Faculty)

Discussion
8:13AM - 8:16AM

Photobiomodulation: CON
8:16AM - 8:21AM
Susan B. Bressler, MD (Faculty)

Photobiomodulation: PRO
8:21AM - 8:26AM
David S Boyer, MD (Faculty)

Debate Discussion
8:26AM - 8:35AM

Honoring Julia A. Haller, MD
8:31AM - 8:34AM
Sunir J. Garg, MD

Novel Anti-VEGF Agents - Clinical Trial vs. Real World Data
8:34AM - 8:40AM
Durga Borkar, MD (Faculty)

Session 2 – Neovascular AMD
8:34AM - 9:28AM
Julia A. Haller, MD (Moderator)
Johanna Seddon , MD (Moderator)

Discussion
8:40AM - 8:43AM

Gene Therapy for Neovascular AMD
8:43AM - 8:49AM
Peter Campochiaro, MD (Faculty)

Discussion
8:49AM - 8:52AM

Rates and Risk Factors for Submacular Hemorrhage in Neovascular Age-Related Macular Degeneration by Anti-Vascular Endothelial Growth Factor Injections
8:52AM - 8:58AM
Matt Starr, MD (Faculty)

Discussion
8:58AM - 9:01AM

Current Management of Subretinal Hemorrhage in Neovascular AMD
9:01AM - 9:07AM
J. Fernando Arevalo, MD, PhD (Faculty)

Discussion
9:07AM - 9:10AM

The Hidden Benefits of a Low Glycemic Index Diet for AMD
9:10AM - 9:16AM
James Handa, MD (Faculty)

Discussion
9:16AM - 9:19AM

AI for Retina Clinical Trials
9:19AM - 9:25AM
Glenn Jaffe, MD (Faculty)

Discussion
9:25AM - 9:28AM

Session 3 – Diabetic Retinopathy and Retinovascular Diseases
9:28AM - 10:22AM
Allen Ho, MD (Moderator)
Yi Zhang, MD, PhD (Moderator)

Some Over-emphasized or Under-appreciated Treatments for Diabetic Retinopathy in 2026
9:28AM - 9:34AM
Neil M. M. Bressler, MD (Faculty)

Discussion
9:34AM - 9:37AM

Proliferative Diabetic Retinopathy: Clinical Practice after DRCR Protocol S
9:37AM - 9:43AM
Adrienne W. Scott, MD (Faculty)

Discussion
9:43AM - 9:46AM

PDS for DR and DME
9:46AM - 9:52AM
Michael Klufas, MD (Faculty)

Discussion
9:52AM - 9:55AM

TKIs in Diabetic Retinopathy and Diabetic Macular Edema
9:55AM - 10:01AM
Katherine Talcott, MD (Faculty)

Discussion
10:01AM - 10:04AM

Reversal of Misfortune - A Rapid OCT-Con?rmed EYESTROKE Treatment (ROCKET) Protocol for Retinal Artery Occlusions Management
10:04AM - 10:10AM
Richard B. Rosen, MD, ScD(hon),FACS, FASRS, FARVO (Faculty)

Discussion
10:10AM - 10:13AM

The Effect of GLP-1s on Age Related Eye Diseases
10:13AM - 10:19AM
Rishi Singh, MD (Faculty)

Discussion
10:19AM - 10:22AM

Break
10:22AM - 10:50AM

Honoring William E. Benson, MD
10:50AM - 10:53AM
Carl D. Regillo, MD

Current Controversies in Surgical Decision Making for Macular Holes
10:53AM - 10:59AM
Donald J. D'Amico, MD (Faculty)

Session 4 – Vitreoretinal Surgery
10:53AM - 11:47AM
Richard S. Kaiser, MD (Moderator)
Meera Sivalingam, MD (Moderator)
William Benson, MD (Moderator)

Discussion
10:59AM - 11:02AM

Large Epiretinal Amniotic Membrane Patch (AMP) for Refractory Macular Hole
11:02AM - 11:08AM
John Miller, MD (Faculty)

Discussion
11:08AM - 11:11AM

IOL Preservation Techniques for Dislocated PC IOLs
11:11AM - 11:17AM
John T. Thompson, MD (Faculty)

Discussion
11:17AM - 11:20AM

Minimizing Retinal Displacement in RRD with Vitrectomy
11:20AM - 11:26AM
Yasha S. Modi, MD (Faculty)

Discussion
11:26AM - 11:29AM

Primary Buckles: To Drain or Not to Drain
11:29AM - 11:35AM
Talia Kaden, MD

Discussion
11:35AM - 11:38AM

PVR Pharmacotherapy - Can we Break Through the Impasse?
11:38AM - 11:44AM
Demetrios Vavvas, MD (Faculty)

Discussion
11:44AM - 11:47AM

Session 5 – Panel: Medical Retina Potpourri
11:47AM - 12:12PM
Tomas S Aleman, MD (Panelist)
Jay Chhablani, MD (Moderator)
Allen Chiang, MD (Panelist)
K. Bailey Freund, MD (Panelist)
Benjamin J. Kim, MD (Panelist)
Sonia Mehta, MD (Panelist)
Brian L. VanderBeek, MD, MPH, MSCE (Panelist)

Lunch
12:12PM - 1:25PM

How to Save a Life
1:25PM - 1:31PM
Jay S Duker, MD (Faculty)

Session 6 – Oncology and Uveitis
1:25PM - 2:28PM
Jordan Deaner, MD (Moderator)
James P. Dunn, MD (Moderator)
Carol L. Shields, MD (Moderator)

Discussion
1:31PM - 1:34PM

High Dose Intravitreal Topotecan for Recurrent Retinoblastoma
1:34PM - 1:40PM
David H Abramson, MD (Faculty)

Discussion
1:40PM - 1:43PM

Use of Intraarterial Chemotherapy Beyond Retinoblastoma
1:43PM - 1:49PM
Jasmine Francis, MD, FACS (Faculty)

Discussion
1:49PM - 1:52PM

What is the Best Treatment for Intraocular Lymphoma?
1:52PM - 1:58PM
Ivana K. Kim, MD (Faculty)

Discussion
1:58PM - 2:01PM

Data Driven Management of Acute Retinal Necrosis
2:01PM - 2:07PM
Thomas A. Albini, MD (Faculty)

Discussion
2:07PM - 2:10PM

Adalimumab vs Conventional Immunosuppression for Uveitis (ADVISE) Trial
2:10PM - 2:16PM
Douglas Jabs, MD, MBA (Faculty)

Discussion
2:16PM - 2:19PM

Updates from the ASRS ReST Committee
2:19PM - 2:25PM
Andre J. Witkin, MD (Faculty)

Discussion
2:25PM - 2:28PM

Introduction to J. Arch McNamara Lecture
2:28PM - 2:33PM
Arunan Sivalingam, MD

J. Arch McNamara Lecture: Title
2:33PM - 2:53PM
Sunil Srivastava, MD (Faculty)

Discussion
2:53PM - 2:58PM

Break
2:58PM - 3:25PM

Special Guest: Lawrence A. Yannuzzi, MD
3:25PM - 3:40PM
Allen Ho, MD (Moderator)
Carol L. Shields, MD (Moderator)
Lawrence A. Yannuzzi, MD (Faculty)

Session 7 – Pediatric Retina & Retinal Degenerations
3:40PM - 4:25PM
Jose Pulido, MD, MS, MPH, MBA (Moderator)
Drew Scoles, MD, PhD (Moderator)

Update on Pediatric Retinal Disease
3:40PM - 3:46PM
Audina M. Berrocal, MD (Faculty)

Discussion
3:46PM - 3:49PM

Pediatric Retinal Imaging: Novel Technology for ROP Screening
3:49PM - 3:55PM
R.V. Paul Chan, MD, MSc, MBA (Faculty)

Discussion
3:55PM - 3:58PM

Optic Disc Pit Maculopathy
3:58PM - 4:04PM
Nicholas Yannuzzi, MD (Faculty)

Discussion
4:04PM - 4:07PM

Gildeuretinol Slows Progression of Stargardt Disease: The TEASE Program
4:07PM - 4:13PM
Philip J. Ferrone, MD (Faculty)

Discussion
4:13PM - 4:16PM

Therapeutic Genome Editing in Retinal Trials
4:16PM - 4:22PM
Stephen H. Tsang, MD (Faculty)

Discussion
4:22PM - 4:25PM

Panel: Surgical Case Adventures
4:25PM - 4:55PM
Dean Eliott, MD (Panelist)
Ajay E. Kuriyan, MD (Panelist)
Ehsan Rahimy, MD (Panelist)
Yoshihiro Yonekawa, MD (Moderator)
Maria Berrocal, MD (Panelist)

Closing Remarks
4:55PM - 5:00PM
Julia A. Haller, MD
Carl D. Regillo, MD
Yoshihiro Yonekawa, MD

See us on Facebook See us on Twitter See us on YouTube See us on Linked In See us on Instagram


©2022 WILLS EYE HOSPITAL 

MISSION PEOPLE ACCREDITATION FAQs GIVING RESEARCH VISIT US PRIVACY POLICY TERMS OF USE